Pharmacokinetic Study of Intranasal Dexmedetomidine in Pediatric Patients With Congenital Heart Disease
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The main objectives of the study are to determine peak plasma drug concentration levels and
corresponding time of dexmedetomidine following intranasal administration in children age ≥1
mo to ≤ 6 yr with congenital heart disease undergoing an elective diagnostic or
interventional cardiac catheterization procedure.